US Patent 8557283 Controlled release formulations of levodopa and uses thereof
Patent 8557283 was granted and assigned to Impax Laboratories on October, 2013 by the United States Patent and Trademark Office.
All edits
Edits on 2 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 20 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08557283 Controlled release formulations of levodopa and uses thereof US Patent 8557283 Controlled release formulations of levodopa and uses thereof
Infobox
Patent Number
0855728300
Patent Number
855728300
Edits on 22 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
085572830
Date of Patent
October 15, 2013
0Patent Application Number
137112480
Date Filed
December 11, 2012
0Patent Primary Examiner
Edits on 27 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
085572830
Date of Patent
October 15, 2013
0Patent Application Number
137112480
Date Filed
December 11, 2012
0Patent Primary Examiner
Edits on 18 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08557283 Controlled release formulations of levodopa and uses thereof
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08557283
Date of patent
October 15, 2013
Patent application number
13711248
Date Filed
December 11, 2012
Patent primary examiner
Find more entities like US Patent 8557283 Controlled release formulations of levodopa and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.